“…Although reference pricing is also beginning to be used to control pharmaceutical expenditures for some organizations in the United States (Robinson, Whaley, & Brown, ), reference pricing is also being applied to other areas of health care such as imaging, laboratory testing, inpatient care (hip and knee replacement), and to our area of interest, outpatient procedures, including arthroscopy, colonoscopy, and cataract surgery (Brown & Robinson, ; Chia‐Hsuan, Wu, & Devries, ; Melton, Bradley, Fu, Armata, & Parr, ; Robinson, Brown, & Whaley, ; Robinson, Brown, & Whaley, ; Robinson, Brown, Whaley, & Bozic, ; Robinson, Brown, Whaley, & Finlayson, ; Robinson, Whaley, & Brown, , ; Robinson, Whaley, & Brown, ; Zhang, Cowling, & Facer, ). Studies of the application of reference pricing to the above three outpatient procedures have found that reference pricing results in reductions in per‐procedure expenditures from 17% to 21% (Robinson, Brown, & Whaley, ; Robinson, Brown, Whaley, & Bozic, ; Robinson, Brown, Whaley, & Finlayson, ). Moreover, reference pricing applied to colonoscopy has been found to constitute an effective cost‐saving policy with substantially lower negative impacts on consumer surplus compared with widely used policies like high‐deductible health plans (Whaley, Guo, & Brown, )…”